Group One Trading
ZVRA icon

Group One Trading’s Zevra Therapeutics ZVRA Stock Holding History

Group One Trading’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
21,300
+20,000
+1,538% +$222K ﹤0.01% 3935
2026
Q1 		$12.1K Sell
1,300
-1,200
-48% -$10.8K ﹤0.01% 6265
2025
Q4 		$22.4K Sell
2,500
-31,500
-93% -$298K ﹤0.01% 6265
2025
Q3 		$323K Buy
34,000
+12,300
+57% +$123K ﹤0.01% 4144
2025
Q2 		$191K Buy
21,700
+2,200
+11% +$17.9K ﹤0.01% 4388
2025
Q1 		$146K Buy
19,500
+18,000
+1,200% +$143K ﹤0.01% 4274
2024
Q4 		$12.5K Sell
1,500
-37,300
-96% -$318K ﹤0.01% 5981
2024
Q3 		$269K Buy
38,800
+27,800
+253% +$189K ﹤0.01% 3357
2024
Q2 		$53.9K Sell
11,000
-1,900
-15% -$9K ﹤0.01% 4475
2024
Q1 		$74.8K Sell
12,900
-25,200
-66% -$155K ﹤0.01% 4392
2023
Q4 		$250K Buy
38,100
+16,900
+80% +$79K ﹤0.01% 3660
2023
Q3 		$102K Sell
21,200
-20,200
-49% -$101K ﹤0.01% 4437
2023
Q2 		$211K Buy
41,400
+12,100
+41% +$65.2K ﹤0.01% 3866
2023
Q1 		$161K Sell
29,300
-29,500
-50% -$156K ﹤0.01% 3866
2022
Q4 		$270K Buy
58,800
+18,900
+47% +$96K ﹤0.01% 3596
2022
Q3 		$249K Buy
39,900
+13,400
+51% +$75.9K ﹤0.01% 3931
2022
Q2 		$118K Sell
26,500
-185,600
-88% -$846K ﹤0.01% 4825
2022
Q1 		$1.07M Sell
212,100
-21,600
-9% -$137K ﹤0.01% 3009
2021
Q4 		$2.04M Buy
233,700
+155,400
+198% +$1.39M ﹤0.01% 2577
2021
Q3 		$731K Buy
78,300
+33,100
+73% +$334K ﹤0.01% 3766
2021
Q2 		$579K Buy
45,200
+18,100
+67% +$195K ﹤0.01% 4062
2021
Q1 		$249K Buy
+27,100
New +$237K ﹤0.01% 4790

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading's ZVRA Position: Q4 2025 in Review

Group One Trading sold out of Zevra Therapeutics (ZVRA) in Q4 2025, closing a stake of 52,638 shares — an estimated $498K sold.

Group One Trading first reported a position in ZVRA in Q3 2018 and held it in 16 quarters. The position peaked at $501K in Q3 2025. 158 funds tracked by Wall St. Rank hold ZVRA as of Q4 2025.

  • Group One Trading reported no remaining Zevra Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 52,638 Zevra Therapeutics shares in Q4 2025, an estimated $498K.
  • Group One Trading first reported a position in Zevra Therapeutics in Q3 2018 and held it in 16 quarters.
  • Group One Trading's Zevra Therapeutics position peaked at $501K in Q3 2025.
  • 158 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.